Eli Lilly’s blockbuster obesity and diabetes drugs Zepbound and Mounjaro are no longer in shortage, according to the Food and ...

The company imports some of its active pharmaceutical ingredient, or semaglutide, into the U.S. for its blockbuster diabetes ...

We recently made a list of the 10 Best Global Stocks To Buy Now. In this piece, we will look at where Novo Nordisk A/S ...

(Bloomberg) -- The obesity-drug hype that fueled huge gains in Novo Nordisk A/S looks to be running out of steam. Novo shares ...

(Reuters) - Danish drugmaker Novo Nordisk has mitigation plans in place to minimize or prevent any disruption to its ...

The healthcare company's pivot into a new set of technologies will have many implications for the stock.

The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

German drug and development company Evotec has entered into a technology development partnership with Novo Nordisk to support ...

AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...

Investing.com – Denmark stocks were lower after the close on Tuesday, as losses in the Oil & Gas, Healthcare and Personal & Household Goods sectors led shares lower ...

Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...

KUWAIT CITY, KUWAIT – Media OutReach Newswire – 2 October 2024 – Novo Nordisk Gulf, a leading global healthcare company, has ...